Alzheimer’s Patients Saluted for Dedication to Drug Trials

GAP-Net site Okanagan Clinical Trials in Kelowna, BC recognized three of its Citizen Scientist Awards nominees in a ceremony at the Okanagan Innovation Centre in downtown Kelowna. A dozen times over two years, Gary Millward and his wife, Debra, drove from Quesnel to Kelowna through everything from wildfires and winter storms to rain and brilliant […]

Read More…

Is an Alzheimer’s Cure on the Horizon?

By the time I was old enough to ask my grandmother questions about her life, it was too late. All I had were skeletons of stories I heard from my mom. I knew that it had been difficult for my grandmother when her parents, Irish immigrants on the vaudeville circuit, left her behind to help […]

Read More…

Dr. Anna Burke Named 2019 Healthcare Innovator of the Year

AzBusiness recognized Dr. Anna Burke as its 2019 Healthcare Innovator of the Year for her work in treating the behavioral and psychiatric disturbances that result from Alzheimer’s disease as well as her work building a community outreach program in the Phoenix area to teach people about brain health, Alzheimer’s, and clinical research. Dr. Burke is […]

Read More…

When It Comes to Alzheimer’s, Important Changes Are Coming for MA Beneficiaries

The majority of experts agree that because Alzheimer’s disease is significantly underdiagnosed and underreported, a large number of people may not know they have it.  We have both spoken at length about the importance of early detection and diagnosis to allow for earlier interventions and care planning along with a broad array of methods and […]

Read More…

In Year Three, GAP Trial Network Is Starting to Hum

Outside the daffodils and forsythia were blooming, but the group assembled in Nashville, Tennessee, hardly took notice. At the GAP-Net Site Optimization Conference, held February 27–March 1, representatives of 61 academic and private clinical trial sites had eyes and minds trained on efforts aiming to improve how Alzheimer’s disease clinical trials are done—and after years […]

Read More…

Addressing the GAPs in Alzheimer’s Trials, Treatment

The Global Alzheimer’s Platform (GAP) Foundation, an organization dedicated to improving Alzheimer’s clinical trials in the quest of a cure, has just wrapped the GAP-NET Site Optimization Conference in Nashville. The Feb. 27-March 1 meeting brought together approximately 150 representatives from its network of Alzheimer’s clinical research sites. The third annual GAP-NET conference attracted the […]

Read More…

Boosting Alzheimer’s trial participation via Medicare Advantage “memory fitness programs”

Clinical trials represent future hope for patients seeking better care, and there is no disease more in need of better care than Alzheimer’s disease. While death rates among most cancers, as well as heart disease, HIV-related illness, and other categories, have declined in the past decade, there has been no progress for Alzheimer’s disease. Better […]

Read More…